Compare WMK & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WMK | ALMR |
|---|---|---|
| Founded | 1912 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 1994 | 2026 |
| Metric | WMK | ALMR |
|---|---|---|
| Price | $78.75 | $31.06 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $37.00 |
| AVG Volume (30 Days) | 142.3K | ★ 728.8K |
| Earning Date | 11-03-2026 | 11-03-2026 |
| Dividend Yield | ★ 1.73% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.95 | N/A |
| Revenue | ★ $4,714,573,000.00 | N/A |
| Revenue This Year | N/A | $64.80 |
| Revenue Next Year | N/A | $37.27 |
| P/E Ratio | $26.87 | ★ N/A |
| Revenue Growth | ★ 0.01 | N/A |
| 52 Week Low | $59.99 | $21.58 |
| 52 Week High | $83.84 | $39.61 |
| Indicator | WMK | ALMR |
|---|---|---|
| Relative Strength Index (RSI) | 54.51 | 50.92 |
| Support Level | $76.47 | $23.87 |
| Resistance Level | $81.50 | $37.81 |
| Average True Range (ATR) | 2.54 | 2.56 |
| MACD | 0.16 | 0.17 |
| Stochastic Oscillator | 47.03 | 51.55 |
Weis Markets Inc is a U.S.-based company that is principally engaged in retailing food products in Pennsylvania and surrounding states. The company's products mainly belong to the following categories: center-store goods, fresh goods, pharmacy services, fuel, and others. The center-store goods include groceries, dairy products, frozen foods, alcoholic beverages, and general merchandise items. The fresh goods include meats, seafood, floral, prepared foods, and bakery products. The company operates in a single segment, which is the retail segment. It derives revenues from customers through the retail sale of products including grocery, pharmacy and fuel from company owned supermarkets. The company derives all its revenue from sales within Pennsylvania and surrounding states.
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.